These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanical circulatory support and heart transplantation in the Asia Pacific region. Sivathasan C; Lim CP; Kerk KL; Sim DK; Mehra MR J Heart Lung Transplant; 2017 Jan; 36(1):13-18. PubMed ID: 28029573 [TBL] [Abstract][Full Text] [Related]
3. Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival. Raffa GM; Di Gesaro G; Sciacca S; Tuzzolino F; Turrisi M; Falletta C; Minà C; Romano G; Vitale G; Panarello G; Clemenza F; Pilato M Int J Cardiol; 2016 Sep; 219():358-61. PubMed ID: 27352207 [TBL] [Abstract][Full Text] [Related]
4. Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT). Zielińska K; Kukulski L; Wróbel M; Przybyłowski P; Rokicka D; Strojek K Ann Transplant; 2022 Feb; 27():e933420. PubMed ID: 35165250 [TBL] [Abstract][Full Text] [Related]
5. Heart transplantation in Japan: a critical appraisal for the results and future prospects. Kitamura S Gen Thorac Cardiovasc Surg; 2012 Oct; 60(10):639-44. PubMed ID: 22898800 [TBL] [Abstract][Full Text] [Related]
6. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation. Vanderlaan RD; Manlhiot C; Edwards LB; Conway J; McCrindle BW; Dipchand AI Pediatr Transplant; 2015 Dec; 19(8):896-905. PubMed ID: 26381803 [TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy. Arora S; Andreassen A; Simonsen S; Gude E; Dahl C; Skaardal R; Hoel I; Geiran O; Gullestad L Transplantation; 2007 Jul; 84(2):149-54. PubMed ID: 17667805 [TBL] [Abstract][Full Text] [Related]
10. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure. Korewicki J Cardiol J; 2009; 16(6):493-9. PubMed ID: 19950084 [TBL] [Abstract][Full Text] [Related]
11. Clinical course and outcome of heart transplant recipients: single center experience at the National Cardiovascular Center in Japan. Oda N; Kato TS; Komamura K; Hanatani A; Mano A; Hashimura K; Asakura M; Niwaya K; Funatsu T; Kobayashi J; Wada K; Hashimoto S; Ishibashi-Ueda H; Nakano Y; Kihara Y; Kitakaze M Int Heart J; 2010 Jul; 51(4):264-71. PubMed ID: 20716844 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients. Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194 [TBL] [Abstract][Full Text] [Related]
13. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study. Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455 [TBL] [Abstract][Full Text] [Related]
14. Impact of adult congenital heart disease on survival and mortality after heart transplantation. Burchill LJ; Edwards LB; Dipchand AI; Stehlik J; Ross HJ J Heart Lung Transplant; 2014 Nov; 33(11):1157-63. PubMed ID: 25049065 [TBL] [Abstract][Full Text] [Related]
15. Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients. De Chiara B; Bigi R; Campolo J; Parolini M; Turazza F; Masciocco G; Frigerio M; Fiorentini C; Parodi O Clin Transplant; 2005 Jun; 19(3):367-71. PubMed ID: 15877800 [TBL] [Abstract][Full Text] [Related]
16. Which advanced heart failure therapy strategy is optimal for patients over 60 years old? Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306 [TBL] [Abstract][Full Text] [Related]
17. Effect of heart transplantation on survival in ambulatory and decompensated heart failure. Banner NR; Rogers CA; Bonser RS; Transplantation; 2008 Dec; 86(11):1515-22. PubMed ID: 19077883 [TBL] [Abstract][Full Text] [Related]
18. Age-Dependent Association Between Pre-transplant Blood Transfusion and Outcomes of Pediatric Heart Transplantation. McKee C; Tumin D; Alevriadou BR; Nicol KK; Yates AR; Hayes D; Tobias JD Pediatr Cardiol; 2018 Apr; 39(4):743-748. PubMed ID: 29340730 [TBL] [Abstract][Full Text] [Related]
19. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602 [TBL] [Abstract][Full Text] [Related]
20. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. Conway J; Manlhiot C; Kirk R; Edwards LB; McCrindle BW; Dipchand AI J Heart Lung Transplant; 2014 Mar; 33(3):241-51. PubMed ID: 24462559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]